Drugs / SLI-F06
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05501327 | Jul 2022 → Jul 2024 overdue | — | Scarless Laboratories, Inc. | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03880058 Comparator | Mar 2019 → May 2021 | — | Scarless Laboratories, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLI-F06 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05501327 ↗ |